explore -WSS

explore

author：focus 2025-10-01 02:12:29 - browse：84

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Can sheer will power keep patients alive in their dying hours?

WSS

Grail spinoff by Illumina should end disastrous merger attempt

HCA sued by state AG for quality issues at Mission Health

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Medicare drug price negotiation hasn't dried up venture capital

Editas, Vertex strike deal on CRISPR

How to keep neuroscience’s past racism from being its future

leisure time

explore

focus

Supreme Court strikes down use of affirmative action

Hospitals owned by private equity see complications spike 25%

Drug repurposing or repositioning? The language matters

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Medical records are filled with copy

How a Boston hospital is priming medical residents to use GPT

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Tori Bowie and the unacceptable rates of Black maternal death

After a decade, new Gardasil ad campaign gets it (mostly) right

leisure time

In rare move, senator releases unverified FBI source report alleging Biden bribe

Medicare drug price negotiation hasn't dried up venture capital

How to keep neuroscience’s past racism from being its future

Prime Medicine, Myeloid Therapeutics clash over genome

Medicare drug price negotiation hasn't dried up venture capital

Carvykti CAR

leisure time

explore

Wikipedia

hotspot